Feature | April 25, 2013

Ten recommendations of fundamental elements of IGRT safety in clinical programs

New ASTRO White Paper Recommends Best Practices for IGRT

April 25, 2013 — The American Society for Radiation Oncology (ASTRO) has issued a new white paper, “Assuring Safety and Quality in Image Guided Delivery of Radiation Therapy,” that recommends best practices to improve the safety and effectiveness of image guided radiation therapy (IGRT), according to the manuscript published as an article in the online journal Practical Radiation Oncology (PRO).

The white paper recommends a set of 10 fundamental elements of IGRT safety in clinical programs and provides an additional list of recommended activities for the broader radiation oncology community to consider.

IGRT is the use of dedicated devices for fraction-by-fraction imaging and guidance of radiation treatment delivery that localizes the target and normal structures to ensure precise and accurate placement of the radiation. IGRT-enabled accuracy and precision allow for highly conformal dose distributions, higher dose prescriptions and shorter fractionation schedules for patients. This requires a strong link between IGRT practices and planning target volume (PTV) design of a patient’s treatment protocol, which is central to high quality, safe radiation therapy.

The manuscript recommends the four major categories for consideration in assuring safe, high-quality radiation therapy using IGRT technologies as

  1. Commissioning and continuing quality assurance (QA) of the systems
  2. Protocols for image acquisition and interpretation
  3. The link between image guidance practices and PTV margin
  4. Education, training and human resources.

 

The 10 foundational elements for safe and effective IGRT practices prescribed by the study are:

  1. Establish a multi-professional team responsible for IGRT activities
  2. Establish and monitor a program of daily, monthly and annual QA for all new or existing IGRT sub-systems
  3. Provide device- and process-specific training for all staff operating IGRT systems or responsible for IGRT delivery
  4. Perform end-to-end testing for all new IGRT procedures and document performance prior to clinical release
  5. Establish process-specific documentation and procedures for IGRT
  6. Clearly identify who is responsible for approval of IGRT correction decisions and the process whereby the decision is made and documented
  7. Establish and document site-specific planning procedures, specifically the procedure for defining PTV margins, and link these planning procedures to IGRT procedures
  8. Multi-professional peer review of PTV volumes, and peer-review of gross tumor volume (GTV) / clinical target volume(CTV) by radiation oncologists
  9. Verify proper creation and transfer of IGRT reference data (PTV, organs at risk (OARs), digitally reconstructed radiographs (DRRs), etc.) to IGRT system
  10. Establish a reporting mechanism for IGRT-related variances in the radiation treatment process. 

 

For more information: www.astro.org, www.practicalradonc.org


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now